Figures computed from official regulatory filings — .
Ownershipinsiders 61.35% · institutions 1.07% · short 0.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for CURAXIS PHARMACEUTICAL Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
5 buys4 sellsbar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| WRIGHT TIMOTHY R | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Geaslen Judith S.T. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Novak Terence | Award | $6K | SEC |
| Leary Stephen J | Award | $8K | Unusual size | SEC |
| GEORGE MICHAEL W | Award | $8K | SEC |
| GOTHNER K IVAN F | Award | $6K | Unusual size | SEC |
| Leary Stephen J | Award | $4.4K | SEC |
| Leary Stephen J | Award | $3.1K | SEC |
| GOTHNER K IVAN F | Award | $5.7K | SEC |
| Novak Terence | Award | $5.7K | SEC |
| GEORGE MICHAEL W | Award | $7.5K | SEC |
| Smith Patrick S | Sell | $82.5K | SEC |
| Smith Patrick S | Sell | $41K | SEC |
| Smith Patrick S | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Geaslen Judith S.T. | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| GEORGE MICHAEL W | Buy | $5K | conv 82ClusterFirst in 12mo | SEC |
| Leary Stephen J | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 23 | SEC |
| Leary Stephen J | Buy | $5K | conv 32 | SEC |
| Smith Patrick S | Sell | $77.5K | SEC |
| Smith Patrick S | Sell | $35K | SEC |
| Miller Michael R | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Geaslen Judith S.T. | Buy | $10K | conv 79First in 12mo | SEC |
| WRIGHT TIMOTHY R | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| GEORGE MICHAEL W | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Leary Stephen J | Buy | $10K | conv 66First in 12mo | SEC |